Both knockdown and inhibition of MAGL by JZL184 can reduce FAs levels and attenuate pathogenicity of melanoma and OVC cells in vitro and in vivo, while overexpression of MAGL displays the opposite phenotype [146, 145]. This evidence concerns the gene MGLL and melanoma.